Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models

about

Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models

Item

http://www.wikidata.org/entity/Q36275656

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Investigation of the In Vitro ...... e cancer cell and tumor models

@ast

Investigation of the In Vitro ...... e cancer cell and tumor models

@en

type

Item

label

Investigation of the In Vitro ...... e cancer cell and tumor models

@ast

Investigation of the In Vitro ...... e cancer cell and tumor models

@en

prefLabel

Investigation of the In Vitro ...... e cancer cell and tumor models

@ast

Investigation of the In Vitro ...... e cancer cell and tumor models

@en

P1476

Investigation of the In Vitro ...... e cancer cell and tumor models

@en

P2093

Bertrand Neveu

http://www.w3.org/2001/XMLSchema#string

Donald Poirier

http://www.w3.org/2001/XMLSchema#string

Frédéric Pouliot

http://www.w3.org/2001/XMLSchema#string

Jenny Roy

http://www.w3.org/2001/XMLSchema#string

Lucie Carolle Kenmogne

http://www.w3.org/2001/XMLSchema#string

René Maltais

http://www.w3.org/2001/XMLSchema#string

P2860

Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.

Cancer statistics, 2015

UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells

Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist

Synthesis and optimization of a new family of type 3 17 beta-hydroxysteroid dehydrogenase inhibitors by parallel liquid-phase chemistry.

Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3.

Human dehydrogenase/reductase (SDR family) member 11 is a novel type of 17β-hydroxysteroid dehydrogenase.

Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer

The Activity of SN33638, an Inhibitor of AKR1C3, on Testosterone and 17β-Estradiol Production and Function in Castration-Resistant Prostate Cancer and ER-Positive Breast Cancer.

Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer.

P304

e0171871

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0171871

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M Rouleau

P577

2017-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28182747

http://www.w3.org/2001/XMLSchema#string

P932

5300232

http://www.w3.org/2001/XMLSchema#string